Harvard bioscience approves restructuring program

Harvard bioscience - on dec 17, board approved a restructuring program to support delivery of its strategic action plan communicated in sept 2019.harvard bioscience - restructuring program will be implemented beginning in current quarter and over 2020.harvard bioscience - restructuring program will entail consolidating and downsizing sites and other headcount reductions in europe & north america.harvard bioscience - restructuring program is expected to be completed by end of 2020.harvard bioscience - restructuring program to deliver annualized run-rate savings of $4.0 million to$5.0 million.
HBIO Ratings Summary
HBIO Quant Ranking